Source:http://linkedlifedata.com/resource/pubmed/id/15127983
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2004-5-6
|
| pubmed:abstractText |
With the emergence of highly resistant beta-lactam gram-positive organisms, vancomycin hydrochloride usage has increased considerably. Consequently, adverse drug reactions, including unfavorable cutaneous events, have also increased. Important adverse skin reactions are linear IgA bullous dermatosis (LABD) and Stevens-Johnson syndrome (SJS). These blistering disorders can have clinical manifestations that are difficult to distinguish; however, it is important to make the distinction because treatment and prognosis are different.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0098-6151
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
104
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
157-63
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:15127983-Adrenal Cortex Hormones,
pubmed-meshheading:15127983-Anti-Bacterial Agents,
pubmed-meshheading:15127983-Diagnosis, Differential,
pubmed-meshheading:15127983-Humans,
pubmed-meshheading:15127983-Outcome and Process Assessment (Health Care),
pubmed-meshheading:15127983-Prognosis,
pubmed-meshheading:15127983-Skin Diseases, Vesiculobullous,
pubmed-meshheading:15127983-Stevens-Johnson Syndrome,
pubmed-meshheading:15127983-Treatment Outcome,
pubmed-meshheading:15127983-Vancomycin
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome.
|
| pubmed:affiliation |
Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA 17033-0850, USA.
|
| pubmed:publicationType |
Journal Article,
Review
|